Literature DB >> 20554525

Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.

Ludovica Riera1, Elena Lasorsa, Chiara Ambrogio, Nadia Surrenti, Claudia Voena, Roberto Chiarle.   

Abstract

Most anaplastic large cell lymphomas (ALCL) express oncogenic fusion proteins derived from chromosomal translocations or inversions of the anaplastic lymphoma kinase (ALK) gene. Frequently ALCL carry the t(2;5) translocation, which fuses the ALK gene to the nucleophosmin (NPM1) gene. The transforming activity mediated by NPM-ALK fusion induces different pathways that control proliferation and survival of lymphoma cells. Grb2 is an adaptor protein thought to play an important role in ALK-mediated transformation, but its interaction with NPM-ALK, as well as its function in regulating ALCL signaling pathways and cell growth, has never been elucidated. Here we show that active NPM-ALK, but not a kinase-dead mutant, bound and induced Grb2 phosphorylation in tyrosine 160. An intact SH3 domain at the C terminus of Grb2 was required for Tyr(160) phosphorylation. Furthermore, Grb2 did not bind to a single region but rather to different regions of NPM-ALK, mainly Tyr(152-156), Tyr(567), and a proline-rich region, Pro(415-417). Finally, shRNA knockdown experiments showed that Grb2 regulates primarily the NPM-ALK-mediated phosphorylation of SHP2 and plays a key role in ALCL cell growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554525      PMCID: PMC2924075          DOI: 10.1074/jbc.M110.116327

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Solution structure of Grb2 reveals extensive flexibility necessary for target recognition.

Authors:  S Yuzawa; M Yokochi; H Hatanaka; K Ogura; M Kataoka; K Miura ; V Mandiyan; J Schlessinger; F Inagaki
Journal:  J Mol Biol       Date:  2001-02-23       Impact factor: 5.469

2.  In vivo interference with Skp1 function leads to genetic instability and neoplastic transformation.

Authors:  Roberto Piva; Jian Liu; Roberto Chiarle; Antonello Podda; Michele Pagano; Giorgio Inghirami
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

3.  Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.

Authors:  Maciej Wiznerowicz; Didier Trono
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma.

Authors:  M Trinei; L Lanfrancone; E Campo; K Pulford; D Y Mason; P G Pelicci; B Falini
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

5.  Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.

Authors:  Hiroshi Hanafusa; Satoru Torii; Takayuki Yasunaga; Eisuke Nishida
Journal:  Nat Cell Biol       Date:  2002-11       Impact factor: 28.824

6.  Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.

Authors:  S Li; A D Couvillon; B B Brasher; R A Van Etten
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

7.  NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

Authors:  Roberto Chiarle; Jerald Z Gong; Ilaria Guasparri; Anna Pesci; Jonjing Cai; Jian Liu; William J Simmons; Girish Dhall; Jennifer Howes; Roberto Piva; Giorgio Inghirami
Journal:  Blood       Date:  2002-11-07       Impact factor: 22.113

8.  The adaptor function of SHP-2 downstream of the prolactin receptor is required for the recruitment of p29, a substrate of SHP-2.

Authors:  Parham Minoo; Naila Chughtai; Manuela Campiglio; Matthias Stein-Gerlach; Jean-Jacques Lebrun; Axel Ullrich; Suhad Ali
Journal:  Cell Signal       Date:  2003-03       Impact factor: 4.315

9.  TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways.

Authors:  Jenny M-Y Ho; Melody H-H Nguyen; Jamil K Dierov; Karla M Badger; Bryan K Beattie; Piero Tartaro; Rizwan Haq; Brent W Zanke; Martin P Carroll; Dwayne L Barber
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

10.  Tyrosine phosphorylation of Grb2: role in prolactin/epidermal growth factor cross talk in mammary epithelial cell growth and differentiation.

Authors:  Eric Haines; Parham Minoo; Zhenqian Feng; Nazila Resalatpanah; Xin-Min Nie; Manuela Campiglio; Laura Alvarez; Eftihia Cocolakis; Mohammed Ridha; Mauricio Di Fulvio; Julian Gomez-Cambronero; Jean-Jacques Lebrun; Suhad Ali
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

View more
  13 in total

1.  Molecular and functional characterizations of the association and interactions between nucleophosmin-anaplastic lymphoma kinase and type I insulin-like growth factor receptor.

Authors:  Bin Shi; Deeksha Vishwamitra; J Gabrielle Granda; Thomas Whitton; Ping Shi; Hesham M Amin
Journal:  Neoplasia       Date:  2013-06       Impact factor: 5.715

Review 2.  ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it.

Authors:  Christian Rolfo; Francesco Passiglia; Marta Castiglia; Luis E Raez; Paul Germonpre; Ignacio Gil-Bazo; Karen Zwaenepoel; Annemieke De Wilde; Giuseppe Bronte; Antonio Russo; Jan P Van Meerbeeck; Paul Van Schil; Patrick Pauwels
Journal:  Transl Lung Cancer Res       Date:  2014-08

3.  A novel model of controlling PD-L1 expression in ALK+ anaplastic large cell lymphoma revealed by CRISPR screening.

Authors:  Jing-Ping Zhang; Zhihui Song; Hong-Bo Wang; Lang Lang; Yuan-Zhong Yang; Wenming Xiao; Daniel E Webster; Wei Wei; Stefan K Barta; Marshall E Kadin; Louis M Staudt; Masao Nakagawa; Yibin Yang
Journal:  Blood       Date:  2019-05-31       Impact factor: 22.113

4.  Pleiotrophin mediates hematopoietic regeneration via activation of RAS.

Authors:  Heather A Himburg; Xiao Yan; Phuong L Doan; Mamle Quarmyne; Eva Micewicz; William McBride; Nelson J Chao; Dennis J Slamon; John P Chute
Journal:  J Clin Invest       Date:  2014-09-24       Impact factor: 14.808

5.  Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors.

Authors:  Guolin Zhang; Hannah Scarborough; Jihye Kim; Andrii I Rozhok; Yian Ann Chen; Xiaohui Zhang; Lanxi Song; Yun Bai; Bin Fang; Richard Z Liu; John Koomen; Aik Choon Tan; James Degregori; Eric B Haura
Journal:  Sci Signal       Date:  2016-10-18       Impact factor: 8.192

6.  The potential for crizotinib in non-small cell lung cancer: a perspective review.

Authors:  Yung-Jue Bang
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

7.  The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs.

Authors:  Peng Xu; Aaron Yun Chen; Safder S Ganaie; Fang Cheng; Weiran Shen; Xiaomei Wang; Steve Kleiboeker; Yi Li; Jianming Qiu
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

8.  NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism.

Authors:  Haifeng Zhu; Deeksha Vishwamitra; Choladda V Curry; Roxsan Manshouri; Lixia Diao; Aarish Khan; Hesham M Amin
Journal:  J Pathol       Date:  2013-03-14       Impact factor: 7.996

9.  ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma.

Authors:  Fabrizio Tabbó; Antonella Barreca; Roberto Piva; Giorgio Inghirami
Journal:  Front Oncol       Date:  2012-05-11       Impact factor: 6.244

10.  NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases.

Authors:  Joel D Pearson; Jason K H Lee; Julinor T C Bacani; Raymond Lai; Robert J Ingham
Journal:  J Signal Transduct       Date:  2012-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.